Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.59 USD | -0.97% | -0.89% | +13.06% |
05:40pm | Gilead Sciences, Inc. Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference, Dec-04-2024 11:40 AM | |
03:26pm | HSBC Adjusts Price Target on Gilead Sciences to $82 From $69 | MT |
Chart calendar Gilead Sciences, Inc.
Upcoming events on Gilead Sciences, Inc.
Past events on Gilead Sciences, Inc.
Today 11:40 am | Evercore ISI HealthCONx Conference |
2024-12-03 11:00 am | Piper Sandler Healthcare Conference |
2024-11-20 04:30 am | Jefferies London Healthcare Conference |
2024-11-09 | Drug Therapy International Congress |
2024-11-06 04:30 pm | Q3 2024 Earnings Call |
2024-11-06 04:02 pm | Q3 2024 Earnings Release |
2024-09-12 | Détachement de |
2024-09-10 10:50 am | Baird Global Healthcare Conference |
2024-09-09 01:45 pm | International Association for the Study of Lung Cancer World Conference - Abstract #OA08.07 |
2024-09-09 01:45 pm | International Association for the Study of Lung Cancer World Conference - Abstract #OA08.06 |
2024-09-08 05:00 pm | International Association for the Study of Lung Cancer World Conference - Abstract #OA04.04 |
2024-09-05 12:20 pm | Morgan Stanley Healthcare Conference |
2024-09-04 11:00 am | Wells Fargo Healthcare Conference |
2024-08-08 04:30 pm | Q2 2024 Earnings Call |
2024-08-08 04:02 pm | Q2 2024 Earnings Release |
2024-06-13 | Détachement de |
2024-06-12 01:20 pm | Goldman Sachs Global Healthcare Conference |
2024-06-05 11:00 am | Jefferies Global Healthcare Conference |
2024-06-03 02:30 pm | American Society of Clinical Oncology Meeting - Abstract No: #TPS8121 |
2024-06-03 02:30 pm | American Society of Clinical Oncology Meeting - Abstract No: #8592 |
Past dividends on Gilead Sciences, Inc.
2024-09-12 | Quarterly 0.77 USD |
2024-06-13 | Quarterly 0.77 USD |
2024-03-13 | Quarterly 0.77 USD |
2023-12-13 | Quarterly 0.75 USD |
2023-09-13 | Quarterly 0.75 USD |
2023-06-13 | Quarterly 0.75 USD |
2023-03-13 | Quarterly 0.75 USD |
2022-12-13 | Quarterly 0.73 USD |
2022-09-13 | Quarterly 0.73 USD |
2022-06-13 | Quarterly 0.73 USD |
2022-03-13 | Quarterly 0.73 USD |
2021-12-13 | Quarterly 0.71 USD |
2021-09-13 | Quarterly 0.71 USD |
2021-06-13 | Quarterly 0.71 USD |
2021-03-11 | Quarterly 0.71 USD |
2020-12-13 | Quarterly 0.68 USD |
2020-09-13 | Quarterly 0.68 USD |
2020-06-10 | Quarterly 0.68 USD |
2020-03-11 | Quarterly 0.68 USD |
2019-12-11 | Quarterly 0.63 USD |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 27 305 26 657 2.43% | 27 281 26 518 2.88% | 27 116 27 083 0.12% | 28 305 | 28 294 | 29 171 |
EBITDA Million USD | Released Forecast Spread | 14 598 15 539 -6.05% | 14 283 13 783 3.63% | 13 177 13 123 0.41% | 10 714 | 14 625 | 15 001 |
EBIT Million USD | Released Forecast Spread | 12 548 13 943 -10.01% | 12 180 12 141 0.32% | 10 484 10 687 -1.9% | 8 251 | 12 394 | 12 889 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 8 278 9 507 -12.92% | 5 814 5 658 2.76% | 6 859 7 323 -6.33% | 498 | 8 429 | 8 908 |
Net income Million USD | Released Forecast Spread | 6 225 7 205 -13.6% | 4 592 4 383 4.77% | 5 665 5 872 -3.52% | 259 | 6 921 | 7 527 |
EPS USD | Released Forecast Spread | 4,93 5,75 -14.19% | 3,64 3,48 4.75% | 4,50 4,69 -3.96% | 0,13 | 5,66 | 6,15 |
Announcement Date | 01/02/22 | 02/02/23 | 06/02/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 6 352 6 326 0.41% | 6 599 6 454 2.24% | 7 051 6 800 3.69% | 7 115 7 104 0.16% | 6 686 6 349 5.31% | 6 954 6 735 3.25% | 7 545 6 999 7.8% | 7 163 | 6 641 | 6 859 | 7 294 | 7 486 |
EBITDA Million USD | Released Forecast Spread | 2 883 3 407 -15.38% | 3 258 3 343 -2.54% | 3 908 3 636 7.49% | 3 427 3 495 -1.94% | -427 -889 51.98% | 3 959 3 365 17.67% | 3 948 3 498 12.86% | 3 197 | ||||
EBIT Million USD | Released Forecast Spread | 2 243 2 658 -15.62% | 2 277 2 776 -17.99% | 3 224 3 060 5.37% | 2 739 2 940 -6.84% | -1 117 -1 679 33.48% | 3 265 2 739 19.18% | 3 258 2 721 19.75% | 2 893 | 2 809 | 2 976 | 3 278 | 3 358 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 300 1 900 -31.59% | 1 588 1 969 -19.35% | 2 318 2 275 1.91% | 1 653 2 090 -20.89% | -4 486 | 2 053 1 733 18.45% | 956 1 652 -42.12% | 2 043 | ||||
Net income Million USD | Released Forecast Spread | 1 010 1 587 -36.37% | 1 045 1 545 -32.38% | 2 180 1 801 21.07% | 1 429 1 599 -10.66% | -4 170 -2 888 -44.38% | 1 614 1 379 17.02% | 1 253 1 335 -6.15% | 1 577 | 1 569 | 1 729 | 1 901 | 2 008 |
EPS USD | Released Forecast Spread | 0,80 1,23 -34.75% | 0,83 1,20 -30.93% | 1,73 1,43 20.88% | 1,14 1,28 -11.05% | -3,34 -1,92 -74.06% | 1,29 1,13 14.13% | 1,00 1,08 -7.48% | 1,37 | 1,27 | 1,44 | 1,65 | 1,69 |
Announcement Date | 27/04/23 | 03/08/23 | 07/11/23 | 06/02/24 | 25/04/24 | 08/08/24 | 06/11/24 | - | - | - | - | - |
Past sector events for Gilead Sciences, Inc.
2024-11-28 | DOTTIKON ES HOLDING AG: Q2 2025 Earnings Release |
2024-11-15 01:38 am | BAVARIAN NORDIC A/S: Q3 2024 Earnings Release |
2024-11-14 11:01 pm | CSPC PHARMACEUTICAL GROUP LTD.: Q3 2024 Earnings Release |
2024-11-14 09:03 am | GUFIC BIOSCIENCES LIMITED: Q2 2025 Earnings Release |
2024-11-14 07:00 am | OCULAR THERAPEUTIX, INC.: Q3 2024 Earnings Release |
2024-11-14 02:49 am | IPCA LABORATORIES LIMITED: Q2 2025 Earnings Release |
2024-11-14 01:30 am | DERMAPHARM HOLDING SE: Q3 2024 Earnings Release |
2024-11-14 01:30 am | ALK-ABELLÓ A/S: Q3 2024 Earnings Release |
2024-11-13 | DONGKOOK PHARMACEUTICAL CO., LTD.: Q3 2024 Earnings Release |
2024-11-13 | HANALL BIOPHARMA CO., LTD.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GILD Stock
- Calendar Gilead Sciences, Inc.